SUBSCRIBE
SUBSCRIBE

Oncorus

NEWS
Oncorus suspended operations in 2023.
What You Need to Know About Oncorus
Business
What You Need to Know About Oncorus
January 3, 2017
 · 
5 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Former bluebird bio CSO Takes the Reins at Oncorus; Startup Launches with $57 Million Series A
July 19, 2016
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Business
Oncorus Announces Workforce Reduction Plan
June 1, 2023
 · 
4 min read
Business
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
May 22, 2023
 · 
7 min read
Business
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 24, 2023
 · 
8 min read
Business
Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug Candidates
January 4, 2023
 · 
7 min read
Genetown
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
November 30, 2022
 · 
8 min read
Genetown
Oncorus to Participate in Upcoming Investor Conferences
November 23, 2022
 · 
1 min read
Drug Development
Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual Meeting
November 18, 2022
 · 
8 min read
Business
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 2, 2022
 · 
9 min read
Drug Development
Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of Cancer
October 7, 2022
 · 
6 min read
Business
Oncorus Appoints Douglas Fambrough to Board of Directors
June 23, 2022
 · 
6 min read
Load More